{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:52:32Z","timestamp":1792212752652,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00432-019-03033-8","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T15:03:13Z","timestamp":1573743793000},"page":"33-41","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Incorporation of Astragalus polysaccharides injection during concurrent chemoradiotherapy in advanced pharyngeal or laryngeal squamous cell carcinoma: preliminary experience of a phase II double-blind, randomized trial"],"prefix":"10.1007","volume":"146","author":[{"given":"Chia-Hsun","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Lung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Hsing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiang-Fu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ta","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Kung","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Chen","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Tung-Chieh","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jr-Rung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4979-509X","authenticated-orcid":false,"given":"Hung-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,14]]},"reference":[{"issue":"14","key":"3033_CR1","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/S0959-8049(00)00186-6","volume":"36","author":"K Bjordal","year":"2000","unstructured":"Bjordal K, de Graeff A, Fayers PM, Hammerlid E, van Pottelsberghe C, Curran D et al (2000) A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer 36(14):1796\u20131807","journal-title":"Eur J Cancer"},{"issue":"10","key":"3033_CR2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrclinonc.2014.127","volume":"11","author":"JE Bower","year":"2014","unstructured":"Bower JE (2014) Cancer-related fatigue\u2013mechanisms, risk factors, and treatments. Nat Rev Clin Oncol 11(10):597\u2013609. https:\/\/doi.org\/10.1038\/nrclinonc.2014.127","journal-title":"Nat Rev Clin Oncol"},{"key":"3033_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jep.2017.06.018","volume":"207","author":"YH Chao","year":"2017","unstructured":"Chao YH, Wu KH, Lin CW, Yang SF, Chao WR, Peng CT, Wu HP (2017) PG2, a botanically derived drug extracted from Astragalus membranaceus, promotes proliferation and immunosuppression of umbilical cord-derived mesenchymal stem cells. J Ethnopharmacol 207:184\u2013191. https:\/\/doi.org\/10.1016\/j.jep.2017.06.018","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"3033_CR4","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.25011\/cim.v35i1.16100","volume":"35","author":"HW Chen","year":"2012","unstructured":"Chen HW, Lin IH, Chen YJ, Chang KH, Wu MH, Su WH, Lai YL (2012) A novel infusible botanically-derived drug, PG2, for cancer-related fatigue: a phase II double-blind, randomized placebo-controlled study. Clin Invest Med 35(1):E1\u2013E11","journal-title":"Clin Invest Med"},{"key":"3033_CR5","doi-asserted-by":"publisher","first-page":"45628","DOI":"10.1038\/srep45628","volume":"7","author":"CC Chen","year":"2017","unstructured":"Chen CC, Chen X, Li TC, Lin HL, Chu YT, Lee HC, Hsieh CL (2017) PG2 for patients with acute spontaneous intracerebral hemorrhage: a double-blind, randomized, placebo-controlled study. Sci Rep 7:45628. https:\/\/doi.org\/10.1038\/srep45628","journal-title":"Sci Rep"},{"issue":"7","key":"3033_CR6","first-page":"515","volume":"22","author":"P Duan","year":"2002","unstructured":"Duan P, Wang ZM (2002) Clinical study on effect of Astragalus in efficacy enhancing and toxicity reducing of chemotherapy in patients of malignant tumor. Zhongguo Zhong Xi Yi Jie He Za Zhi 22(7):515\u2013517","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"9","key":"3033_CR7","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/annonc\/mdx299","volume":"28","author":"MG Ghi","year":"2017","unstructured":"Ghi MG, Paccagnella A, Ferrari D, Foa P, Alterio D, Codeca C et al (2017) Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial. Ann Oncol 28(9):2206\u20132212. https:\/\/doi.org\/10.1093\/annonc\/mdx299","journal-title":"A phase II-III trial. Ann Oncol"},{"issue":"5","key":"3033_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4103\/2319-4170.113375","volume":"36","author":"CH Hsieh","year":"2013","unstructured":"Hsieh CH, Hsu CL, Wang CH, Liaw CC, Chen JS, Chang HK, Wang HM (2013) Cisplatin, tegafur-uracil and leucovorin plus mitomycin C: an acceptably effective and toxic regimen for patients with recurrent or metastatic nasopharyngeal carcinoma. Biomed J 36(5):229\u2013236. https:\/\/doi.org\/10.4103\/2319-4170.113375","journal-title":"Biomed J"},{"issue":"2","key":"3033_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bj.2018.04.003","volume":"41","author":"PW Huang","year":"2018","unstructured":"Huang PW, Lin CY, Hsieh CH, Hsu CL, Fan KH, Huang SF, Wang HM (2018) A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx. Biomed J 41(2):129\u2013136. https:\/\/doi.org\/10.1016\/j.bj.2018.04.003","journal-title":"Biomed J"},{"key":"3033_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081054","author":"WC Huang","year":"2019","unstructured":"Huang WC, Kuo KT, Bamodu OA, Lin YK, Wang CH, Lee KY, Wang LS, Yeh CT, Tsai JT (2019) Astragalus polysaccharide (PG2) ameliorates cancer symptom clusters, as well as improves quality of life in patients with metastatic disease, through modulation of the inflammatory cascade. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11081054","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3033_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S0885-3924(03)00218-5","volume":"26","author":"SS Hwang","year":"2003","unstructured":"Hwang SS, Chang VT, Rue M, Kasimis B (2003) Multidimensional independent predictors of cancer-related fatigue. J Pain Symptom Manage 26(1):604\u2013614","journal-title":"J Pain Symptom Manage"},{"key":"3033_CR12","doi-asserted-by":"publisher","first-page":"917345","DOI":"10.1155\/2015\/917345","volume":"2015","author":"YL Kuo","year":"2015","unstructured":"Kuo YL, Chen CH, Chuang TH, Hua WK, Lin WJ, Hsu WH, Huang CY (2015) Gene expression profiling and pathway network analysis predicts a novel antitumor function for a botanical-derived drug, PG2. Evid Based Complement Alternat Med 2015:917345. https:\/\/doi.org\/10.1155\/2015\/917345","journal-title":"Evid Based Complement Alternat Med"},{"key":"3033_CR13","first-page":"919","volume":"35","author":"XJJY Li","year":"2008","unstructured":"Li XJJY, Sun YY et al (2008) Clinical efficacy of Astragalus polysaccharide injection combined with chemotherapy for treatment of advanced non-small cell lung cancer. Chin J Clin Oncol 35:919\u2013921","journal-title":"Chin J Clin Oncol"},{"key":"3033_CR14","first-page":"310","volume":"14","author":"X Lou","year":"2003","unstructured":"Lou X, Zhang B, Song J et al (2003) Effct of Astragalus polysaccharide in stimulating the secretion of hematopoietic growth factors from activated human PBMC. Tradit Chin Drug Res Clinical Pharmacol 14:310\u2013315","journal-title":"Tradit Chin Drug Res Clinical Pharmacol"},{"issue":"5","key":"3033_CR15","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N","volume":"85","author":"TR Mendoza","year":"1999","unstructured":"Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL (1999) The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 85(5):1186\u20131196","journal-title":"Cancer"},{"issue":"11A","key":"3033_CR16","first-page":"151","volume":"14","author":"V Mock","year":"2000","unstructured":"Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C, National Comprehensive Cancer N (2000) NCCN practice guidelines for cancer-related fatigue. Oncology (Williston Park) 14(11A):151\u2013161","journal-title":"Oncology (Williston Park)"},{"issue":"2","key":"3033_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ctim.2008.11.002","volume":"17","author":"A Molassiotis","year":"2009","unstructured":"Molassiotis A, Potrata B, Cheng KK (2009) A systematic review of the effectiveness of Chinese herbal medication in symptom management and improvement of quality of life in adult cancer patients. Complement Ther Med 17(2):92\u2013120. https:\/\/doi.org\/10.1016\/j.ctim.2008.11.002","journal-title":"Complement Ther Med"},{"issue":"9208","key":"3033_CR18","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","volume":"355","author":"JP Pignon","year":"2000","unstructured":"Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355(9208):949\u2013955","journal-title":"Lancet"},{"issue":"2 Suppl","key":"3033_CR19","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/j.ijrobp.2007.04.088","volume":"69","author":"JP Pignon","year":"2007","unstructured":"Pignon JP, Lemaitre A, Bourhis J, Group, M.-N. C (2007) Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 69(2 Suppl):S112\u2013S114. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.04.088","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"3033_CR20","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.bbrc.2004.06.065","volume":"320","author":"BM Shao","year":"2004","unstructured":"Shao BM, Xu W, Dai H, Tu P, Li Z, Gao XM (2004) A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biophys Res Commun 320(4):1103\u20131111. https:\/\/doi.org\/10.1016\/j.bbrc.2004.06.065","journal-title":"Biochem Biophys Res Commun"},{"key":"3033_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1758-3284-2-32","volume":"2","author":"AP Silveira","year":"2010","unstructured":"Silveira AP, Goncalves J, Sequeira T, Ribeiro C, Lopes C, Monteiro E, Pimentel FL (2010) Patient reported outcomes in head and neck cancer: selecting instruments for quality of life integration in clinical protocols. Head Neck Oncol 2:32. https:\/\/doi.org\/10.1186\/1758-3284-2-32","journal-title":"Head Neck Oncol"},{"key":"3033_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1477-7525-9-70","volume":"9","author":"L Uwer","year":"2011","unstructured":"Uwer L, Rotonda C, Guillemin F, Miny J, Kaminsky MC, Mercier M, Conroy T (2011) Responsiveness of EORTC QLQ-C30, QLQ-CR22 and FACT-C quality of life questionnaires in patients with colorectal cancer. Health Qual Life Outcomes 9:70. https:\/\/doi.org\/10.1186\/1477-7525-9-70","journal-title":"Health Qual Life Outcomes"},{"issue":"17","key":"3033_CR23","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/nejmoa071028","volume":"357","author":"JB Vermorken","year":"2007","unstructured":"Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M et al (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357(17):1695\u20131704. https:\/\/doi.org\/10.1056\/nejmoa071028","journal-title":"N Engl J Med"},{"issue":"3 Suppl 2","key":"3033_CR24","first-page":"4","volume":"34","author":"NJ Vogelzang","year":"1997","unstructured":"Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, Portenoy RK (1997) Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 34(3 Suppl 2):4\u201312","journal-title":"Semin Hematol"},{"issue":"11","key":"3033_CR25","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1002\/cncr.10570","volume":"94","author":"HM Wang","year":"2002","unstructured":"Wang HM, Wang CS, Chen JS, Chen IH, Liao CT, Chang TC (2002) Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Cancer 94(11):2989\u20132995. https:\/\/doi.org\/10.1002\/cncr.10570","journal-title":"Cancer"},{"issue":"4","key":"3033_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/00001813-200504000-00012","volume":"16","author":"HM Wang","year":"2005","unstructured":"Wang HM, Hsueh CT, Wang CS, Chen IH, Liao CT, Tsai MH, Chang JT (2005) Phase II trial of cisplatin, tegafur plus uracil and leucovorin as neoadjuvant chemotherapy in patients with squamous cell carcinoma of the oropharynx and hypopharynx. Anticancer Drugs 16(4):447\u2013453","journal-title":"Anticancer Drugs"},{"issue":"3","key":"3033_CR27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/ptr.2958","volume":"24","author":"YF Wang","year":"2010","unstructured":"Wang YF, Yang XF, Cheng B, Mei CL, Li QX, Xiao H, Liu K (2010) Protective effect of Astragalus polysaccharides on ATP binding cassette transporter A1 in THP-1 derived foam cells exposed to tumor necrosis factor-alpha. Phytother Res 24(3):393\u2013398. https:\/\/doi.org\/10.1002\/ptr.2958","journal-title":"Phytother Res"},{"key":"3033_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11020128","author":"CH Wang","year":"2019","unstructured":"Wang CH, Lin CY, Chen JS, Ho CL, Rau KM, Tsai JT et al (2019) Karnofsky performance status as a predictive factor for cancer-related fatigue treatment with Astragalus polysaccharides (PG2) injection-a double blind, multi-center. Randomized phase IV study. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11020128","journal-title":"Cancers (Basel)"},{"key":"3033_CR29","first-page":"208","volume":"44","author":"ZP Zheng","year":"2013","unstructured":"Zheng ZP, Yang W, Li N et al (2013) Clinical observation on injection of Astragalus polysaccharides protecting marrow suppression of non-small-cell lung cancer after chemotherapy. Chin Tradit Herbal Drugs 44:208\u2013209","journal-title":"Chin Tradit Herbal Drugs"},{"issue":"10","key":"3033_CR30","first-page":"733","volume":"23","author":"YH Zou","year":"2003","unstructured":"Zou YH, Liu XM (2003) Effect of Astragalus injection combined with chemotherapy on quality of life in patients with advanced non-small cell lung cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 23(10):733\u2013735","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-03033-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-019-03033-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-03033-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:18:35Z","timestamp":1605226715000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-019-03033-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,14]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["3033"],"URL":"https:\/\/doi.org\/10.1007\/s00432-019-03033-8","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,14]]},"assertion":[{"value":"10 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was granted by the Institutional Review Board of Chang Gung Memorial Hospital at Linkou, and all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}